Hansa Biopharma to participate in the BioStock Life Science Summit
Lund, Sweden, October 30. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced that Renée Aguiar-Lucander, CEO, Hansa Biopharma, will participate in a panel titled “Closing the Deal – Nordic Success Stories” at the BioStock Life Science Summit, on Wednesday 4 November, at 12:25 CET, at the Elite Hotel Ideon in Lund.
